http://www.unboundmedicine.com/medline/ebm/research/QuinoraUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19049252/full_citation/Validation_of_the_use_of_nonnaive_surgically_catheterized_rats_for_pharmacokinetics_studies_Deshmukh SV, Durston J, Shomer NH 
Validation of the use of nonnaive surgically catheterized rats for pharmacokinetics studies. [Journal Article]
J Am Assoc Lab Anim Sci 2008 Nov; 47(6):41-5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19048359/full_citation/Grapefruit_Juice_and_its_Constituents_Augment_Colchicine_Intestinal_Absorption:_Potential_Hazardous_Interaction_and_the_Role_of_P_Glycoprotein_Dahan A, Amidon GL 
Grapefruit Juice and its Constituents Augment Colchicine Intestinal Absorption: Potential Hazardous Interaction and the Role of P-Glycoprotein. [JOURNAL ARTICLE]
Pharm Res 2008 Dec 2.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19036667/full_citation/Termination_of_equine_atrial_fibrillation_by_quinidine:_An_optical_mapping_study_Fenton FH, Cherry EM, Kornreich BG 
Termination of equine atrial fibrillation by quinidine: An optical mapping study. [JOURNAL ARTICLE]
J Vet Cardiol 2008 Nov 24.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19019305/full_citation/Therapeutic_Strategies_in_Congenital_Myasthenic_Syndromes_Schara U, Lochmüller H 
Therapeutic Strategies in Congenital Myasthenic Syndromes. [JOURNAL ARTICLE]
Neurotherapeutics 2008 Oct; 5(4):542-547.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19011672/full_citation/Influence_of_quinidine_fluvoxamine_and_ketoconazole_on_the_enantioselective_pharmacokinetics_of_citalopram_in_rats_Rocha A, Coelho EB, Lanchote VL 
Influence of quinidine, fluvoxamine, and ketoconazole on the enantioselective pharmacokinetics of citalopram in rats. [Journal Article]
Can J Physiol Pharmacol 2008 Nov; 86(11):770-6.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19000552/full_citation/Effect_of_CYP2D6_polymorphism_on_pharmacokinetics_of_a_novel_ACAT_inhibitor_pactimibe_and_its_unique_metabolite_R_125528_Kotsuma1 M, Tokui1 T, Freudenthaler2 S, et al. 
Effect of CYP2D6 polymorphism on pharmacokinetics of a novel ACAT inhibitor, pactimibe and its unique metabolite, R-125528. [JOURNAL ARTICLE]
Int J Clin Pharmacol Ther 2008 Nov; Volume 46(November):545-555.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19000368/full_citation/Modulating_effect_of_polyethylene_glycol_on_the_intestinal_transport_and_absorption_of_prednisolone_methylprednisolone_and_quinidine_in_rats_by_in_vitro_and_in_situ_absorption_studies_Shen Q, Li W, Lin Y, et al. 
Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies. [Journal Article]
J Pharm Pharmacol 2008 Dec; 60(12):1633-41.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18997493/full_citation/The_use_of_phosphodiesterase_5_inhibitors_with_concomitant_medications_Corona G, Razzoli E, Forti G, et al. 
The use of phosphodiesterase 5 inhibitors with concomitant medications. [Journal Article]
J Endocrinol Invest 2008 Sep; 31(9):799-808.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18986334/full_citation/POSSIBLE_PARTICIPATION_OF_CHLORIDE_ION_CHANNELS_IN_ATP_RELEASE_FROM_CANCER_CELLS_IN_SUSPENSION_Nejime N, Kagota S, Tada Y, et al. 
POSSIBLE PARTICIPATION OF CHLORIDE ION CHANNELS IN ATP RELEASE FROM CANCER CELLS IN SUSPENSION. [JOURNAL ARTICLE]
Clin Exp Pharmacol Physiol 2008 Sep 26.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18981167/full_citation/The_carnitine_transporter_SLC22A5_is_not_a_general_drug_transporter_but_it_efficiently_translocates_mildronate_Grigat S, Fork C, Bach M, et al. 
The carnitine transporter SLC22A5 is not a general drug transporter, but it efficiently translocates mildronate. [JOURNAL ARTICLE]
Drug Metab Dispos 2008 Nov 3.
Abstract | Full Citation | Find Related Articles